AASLD is actively monitoring events related to the COVID-19 pandemic and will provide timely information and resources to support health care providers in hepatology, liver transplantation and gastroenterology as well as their patients and caregivers. This resource page will be updated regularly as more data become available to the AASLD Leadership.

"COVID-19 and the Liver" Webinar Series

In response to the COVID-19 pandemic, AASLD has created a series of webinars dedicated to ongoing discoveries and discussions about how it affects the care of liver patients. These webinars, including those in which we collaborated with sister organizations, are located on the "COVID-19 and the Liver Webinar Series" page.


AASLD Creates Expert Panel Consensus Statement: "Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease"

The goal of this document is to provide concise safety and efficacy data regarding the commercially available COVID-19 vaccines and their use in CLD patients and liver transplant recipients. Our intent is to provide clinically useful information for hepatologists, liver transplant care providers, and their patients. This online document will be updated regularly as more data become available and additional vaccines are authorized for use.

For the Clinician

  • Mental Health and Burnout Resources
  • Joint Society Messages

Download AASLD's curated list of resources for mental health, stress and burnout.

AASLD's Clinical and Public Policy Positions

  • The Administration
  • Congress
  • Centers for Disease Control and Prevention
  • Centers for Medicare & Medicaid Services

AASLD joins 200 Organizations in Letter to Administration regarding PPE and Ventilators

Read the joint societies' letter to the Administration.

AASLD's "Clinical Best Practice ADVICE for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD EXPERT PANEL CONSENSUS STATEMENT"

This document provides data on what is known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a basic template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and health care providers. This document will continue to evolve and be reviewed by the authors and AASLD Governing Board, and be revised and updated as needed in response to the COVID-19 pandemic.

For Trainees / Early Career Health Care Professionals

Download the Q&A document from the "Trainee and Early Career Experience in Hepatology during COVID-19" webinar.

For Patients

AASLD Multimedia Resources

  • Dilemmas in clinical management
  • Journal club audio podcasts

"How I Approach It" Series

What You Can Do

  • Actions You Can Take

AASLD seeks COVID-19 Manuscript Submissions

Read the letter from AASLD journal Editors-in-Chief David Cohen, Paul Martin and Gyongyi Szabo.

COVID-19 Discussion Community in Engage

AASLD members have an outlet to share and discuss COVID-19 and how it's affecting care delivery to patients with liver disease.

Join the conversation.

Write your Congressional Representatives and Senators

Join us and make your voice heard: Use our online advocacy tool to send an email to your legislators about how COVID-19 is impacting you and what needs to be done to protect you, your colleagues and your patients during this urgent time.


Journal References for COVID-19

  • AASLD Journal Articles
  • Resources from Other Publishers


Clinical Liver Disease

Liver Transplantation

Hepatology Communications

Other COVID-19 Resources

  • American Medical Association
  • Centers for Disease Control and Prevention
  • Centers for Medicare and Medicaid Services
  • Fellow Hepatology, GI and Transplant Organizations
  • Food & Drug Administration
  • Health & Human Services
  • Health Care Resiliency Taskforce
  • National Institutes of Health
  • SECURE-Cirrhosis
  • AABB
  • AASLD News
  • For Patients